Non-Hodgkin's Lymphoma Survival Rate by Stage

This article looks at the Non-Hodgkin's Lymphoma survival rate as well as the Non-Hodgkin's Lymphoma mortality rate . Non-Hodgkin's lymphoma (NHL) is a very broad term for cancers affecting the lymphocytes in the body's immune system and varying the Non-Hodgkin lymphoma survival rate. The disease generally presents as painless, rubbery swollen lymph nodes in the neck, clavicle or groin, although lymphoma can originate virtually anywhere in the body—in lymph nodes or beyond them—because the lymphatic system, which carries lymphocytes, traverses the whole body.

According to statistics from the last forty years, lymphomas constitute one of the fastest-growing cancer categories in the United States, and they are among the handful of most frequently diagnosed cancers in the country. However, this may not be a true representation of the frequency of the disease since more and more subtypes of NHL are identified every year, which is almost without doubt leading to more diagnoses.

Incidence and Mortality Rate of Non-Hodgkin's Lymphoma

Each year, approximately 65,500 people in the US will receive a diagnosis of non-Hodgkin's lymphoma, and over 20,000 people will succumb to the disease annually.

The median age at diagnosis for non-Hodgkin's lymphoma is 66. About two-thirds of all NHLs are diagnosed between the ages of 55 and 84, and there is a slightly higher incidence among men versus women. The life expectancy or the median age at death for this broad cancer is 75; about one-third of all deaths from NHL occurs between the ages of 75 and 84.

Non-Hodgkin's Lymphoma Survival Rate by Stage

According to data published by the National Cancer Institute's Surveillance Epidemiology and End Results (SEER), one has reason to be optimistic about reviewing the Non-Hodgkin lymphoma survival rate. The Non-Hodgkin lymphoma survival rates expressed in terms of 5-year relative survival, meaning the percentage of people expected to be alive five years after initial diagnosis are quite impressive when set against many other cancers, and it is evident that early detection favors long-term survival. This is why it is important not to discuss this in terms of a Non Hodgkin's Lymphoma cure rate. A person, after treatment, may go into remission and below are the NHL survival rates:

  • Stage 1 Non-Hodgkin's Lymphoma survival rate: Early-stage (I), localized disease: 81.1%
  • Stage 1 and Stage 2 Non-Hodgkin's Lymphoma survival rate: Early-stage (I, II), regional disease: 70.5%
  • Stage 3 and Stage 4 Non-Hodgkin's Lymphoma survival rate: Later-stage (III, IV), metastasized disease: 58.5%

These 5 year relative Non-Hodgkin lymphoma survival rate reflect one of medicine's few major victories in the fight against cancer, and the field of effective treatment options is growing every year.

Source: National Cancer Institute SEER Stat Fact Sheets: Non-Hodgkin's Lymphomas
Photo: [SOURCE]

More Articles

More Articles

This entry looks at Non Hodgkin's Lymphoma in the lungs, clinically known as pulmonary lymphoma, one of the subtypes of lymphoma. 'Lymphoma' is an...

In order to prevent developing any subtype of lymphoma, it would be helpful to know the causes of lymphoma. Unfortunately, in virtually every case...

BEAM chemotherapy is an acronym representing a small family of combination chemotherapy regimens that are used chiefly as salvage regimens in the...

There are two types of cancer: benign and malignant. Benign cancers are the kind that don't spread and don't threaten one's life. Malignant...

The Erythrocyte Sedimentation Rate (ESR - sometimes called sed rate or sedimentation rate) is a nonspecific screening test for various...

Blood counts can be used to identify disease and monitor patient health during cancer treatments. Though these tests cannot diagnose lymphoma on...

MALT lymphoma is a rare B-cell non-Hodgkin's lymphoma that typically runs an indolent or slow-growing clinical...

Mantle cell lymphoma (MCL) is just one of 50-60 known B-cell subtypes of...

After some of the dust has settled, the thoughts of many new lymphoma patients turn to diet and nutrition. They want to know if, in the past,...

According to a study by Japanese researchers, the SMILE combination chemotherapy protocol is effective against extranodal natural killer/T-cell...

In a perfect world, every case of cancer would respond to, and be cured by first-line therapy. Unfortunately, it is not often the case. This is...

Patients treated with maintenance rituximab had three times longer progression-free survival. This is a summary of an article published in the...

Prednisone is a glucocorticosteroid (a steroid) used in the treatment of many types of cancers. It functions as an anti-inflammatory medicine that...

In 1964, researchers at the National Cancer Institute developed the first combination chemotherapy that cured a...

Since so many chemotherapy agents can affect a patient’s sex drive and fertility, thinking about these issues prior...